Provided by Tiger Trade Technology Pte. Ltd.

Forte BioSciences Inc

76.92
+0.03000.04%
Post-market: 76.940.0200+0.03%19:49 EDT
Volume:2.01M
Turnover:154.80M
Market Cap:1.63B
PE:-16.92
High:76.95
Open:76.94
Low:76.89
Close:76.89
52wk High:77.20
52wk Low:10.11
Shares:21.23M
Float Shares:19.00M
Volume Ratio:0.88
T/O Rate:10.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5455
EPS(LYR):-4.7137
ROE:-62.28%
ROA:-37.79%
PB:8.88
PE(LYR):-16.32

Loading ...

Sandisk, Marvell, Chevron, Broadcom, and More Stocks That Explain Today's Market

Dow Jones
·
Jul 27

Deals of the day-Mergers and Acquisitions

Reuters
·
Jul 27

Argenx to Buy Forte Biosciences for About $2.2 Billion

Reuters
·
Jul 27

Forte Biosciences Shares Climb 21.3% Premarket After Argenx Agrees to Near $2.2 Bln Buyout of Co

THOMSON REUTERS
·
Jul 27

PRESS Digest -Wall Street Journal - July 27

Reuters
·
Jul 27

Argenx to Buy Forte Biosciences for USD 77 a Share in USD 2.2 Billion Deal

Reuters
·
Jul 27

Forte Biosciences Initiated at Overweight by Barclays

Dow Jones
·
Jul 21

Forte Biosciences initiated with an Overweight at Barclays

TIPRANKS
·
Jul 21

Analysts Offer Insights on Healthcare Companies: Forte Biosciences (FBRX), Sarepta Therapeutics (SRPT) and Opus Genetics (IRD)

TIPRANKS
·
Jul 10

Top Midday Gainers

MT Newswires Live
·
Jul 10

U.S. Stocks on the Move-natera, Nlight, Micron

Reuters
·
Jul 10

Forte Biosciences Shares Jump on Positive Vitiligo Study Results

Dow Jones
·
Jul 09

Forte Biosciences trading halted, volatility trading pause

TIPRANKS
·
Jul 09

Forte Biosciences Rises After Skin Disorder Drug Shows Early Promise

Reuters
·
Jul 09

Forte Biosciences Says FB102 Hits Statistically Significant Vitiligo Improvement in Phase 1b Trial at Week 24

Reuters
·
Jul 09

Forte Biosciences - FB102 Demonstrates Strong Safety Profile with Only Mild to Moderate Adverse Events

THOMSON REUTERS
·
Jul 09

Forte Biosciences - Announces Positive FB102 Phase 1B Vitiligo Study Results

THOMSON REUTERS
·
Jul 09

Forte Biosciences - 84% of FB102 Subjects Improved from Baseline to Week 24; 0% Worsened

THOMSON REUTERS
·
Jul 09

Forte Biosciences Files $500 Million Mixed Shelf

MT Newswires Live
·
Jun 03

Forte Biosciences - May Offer up to $500 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Jun 03